Brief: Pharvaris NV reports Q2 results
Sept 12 (Reuters) - Pharvaris NV PHVS.O :
* PHARVARIS REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
AND
PROVIDES BUSINESS UPDATE
* PHARVARIS NV Q2 LOSS PER SHARE EUR 0.38
Source text for Eikon: ID:nGNX4S8TF5
Further company coverage: PHVS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pharvaris
See all newsU.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple
U.S. STOCKS ON THE MOVE-Qualcomm, Eaton, Howmet Aerospace
Pharvaris' genetic disorder drug meets main goal in late-stage trial (updated)
U.S. STOCKS ON THE MOVE-Sigma Lithium, Shake Shack, Novartis
Pharvaris gains after genetic disorder drug meets late-stage trial goal